Merck KGaA (OTCMKTS:MKGAF – Get Free Report) is expected to release its results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of $2.31 per share and revenue of $6.0418 billion for the quarter.
Merck KGaA Stock Up 3.4%
Shares of MKGAF stock opened at $170.60 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company’s fifty day moving average price is $160.67 and its 200-day moving average price is $147.40. The company has a market capitalization of $22.05 billion, a price-to-earnings ratio of 26.05 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
